BLOG - Women in Research

Women in Research #LINO23: Trishla Sinha

Ulrike Böhm

Women in Research #LINO23: Trishla Sinha

Trishla Sinha, PhD student at the University Medical Center Groningen, aims to identify factors that shape the maternal and infant gut microbiomes and viromes, focusing on birth and environmental factors.

Women in Research #LINO23: Liyana Binti Azmi

Ulrike Böhm

Women in Research #LINO23: Liyana Binti Azmi

Liyana is a lecturer at University Sains Islam Malaysia. Her research focuses primarily on antimicrobial resistance (AMR) through understanding protein structure and functions.

Women in Research #LINO23: Magdalena Migalska

Ulrike Böhm

Women in Research #LINO23: Magdalena Migalska

Magdalena from Poland is a Postdoc at Jagiellonian University, Krakow, Poland. She studies the evolution of the vertebrate immune system, focusing on the major histocompatibility complex (MHC) – a set of molecules central to molecular self/non-self recognition and the adaptive immune response.

Women in Research #LINO23: Mirian Krystel De Siqueira

Ulrike Böhm

Women in Research #LINO23: Mirian Krystel De Siqueira

Mirian from Brazil is a Ph.D. Candidate at the University of California, Los Angeles, CA, USA. Her current research interests rely on understanding the landscape of translation regulation in the development of obesity and systemic metabolism.

Women in Research #LINO23: Mónica Rivera-Franco

Ulrike Böhm

Women in Research #LINO23: Mónica Rivera-Franco

Mónica from Mexico is a Medical Researcher at Eurocord Paris, France. Her research focuses on epidemiological and translational research in the fields of human leukocyte antigens, cord blood transplantation, and cellular therapies for benign and malignant hematological diseases.

Women in Research #LINO23: Zuzanna Kozicka

Ulrike Böhm

Women in Research #LINO23: Zuzanna Kozicka

Zuzanna from Poland is a Ph.D. graduate at the Friedrich Miescher Institute in Biomedical Research, Basel, Switzerland. Her research focuses on molecular glue degraders, a new paradigm in drug discovery that allows targeted destruction of disease-causing proteins.

Women in Research #LINO23: Lianna Wat

Ulrike Böhm

Women in Research #LINO23: Lianna Wat

Lianna from Canada is a postdoctoral researcher at Stanford University, CA, USA. She leverages the study of male-female differences to discover novel metabolic hormones and genes that control how women and men regulate their metabolism differently.

Women in Research #LINO23: Mari Carmen Romero-Mulero

Ulrike Böhm

Women in Research #LINO23: Mari Carmen Romero-Mulero

Mari Carmen from Spain is a Ph.D. student at the Max Planck Institute of Immunobiology and Epigenetics and the Faculty of Biology, University of Freiburg, Germany. Her project focuses on the assessment of the effect of aging on the physiology of the hematopoietic compartment.

Women in Research #LINO23: Sanne Boersma

Ulrike Böhm

Women in Research #LINO23: Sanne Boersma

Sanne Boersma hopes to contribute to solving some of the mysteries of our cells and our tissues. Currently, she is very much fascinated by the complicated ‘tug-of-war’ between a virus and the infected tissue during infection.

Women in Research #LINO23: Nabila Ismail

Ulrike Böhm

Women in Research #LINO23: Nabila Ismail

Nabila is very keen on investigating how specific drugs work within the bacteria that causes TB: Mycobacterium tuberculosis.

Women in Research #LINO23: Yanira Méndez Gómez

Ulrike Böhm

Women in Research #LINO23: Yanira Méndez Gómez

Yanira from Cuba is a Marie Skłodowska-Curie Postdoctoral Fellow at the University of Cambridge, United Kingdom. Yanira’s research, which she conducts at Prof. Dr. Gonςalo Bernardes’ group, focuses on the discovery of new multicomponent reactions and their application on protein modification.

Women in Research #LINO23: Flávia Sousa

Ulrike Böhm

Women in Research #LINO23: Flávia Sousa

As a Senior Researcher at the Adolphe Merkle Institute, University of Fribourg, Switzerland, Flávia Sousa's research work has been pioneering regarding the encapsulation of anti-angiogenic monoclonal antibodies and understanding the efficacy in treating glioblastoma by normalizing the tumor vasculature and microenvironment.